Stock·NYSE·Industrials
FedEx Corp. (FDX)
- Market cap
- $69.47B
- P/E
- 15.82
- Dividend yield
- 1.63%
- Street target
- $352.50median of 28 analysts
- 52-week range
- $188.98 $345.37
The short version
Where FDX stands today, in four lines, and what CleaRank Financial AI makes of it.
FDX at a glance
FedEx Corp. (FDX): Hold, 58/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($309.38 and $301.91).
- Earnings FDX beat estimates in 5 of its last 7 quarters, yet fell the next day after 3 of those beats.
- Insiders Insiders sold $23.3M and made no open-market purchases over the last 18 months.
- Valuation P/E of 15.8 against 34.0 for the Industrials sector: a discount to peers (-53%).
Figures as of October 17, 2026.
CleaRank Financial AI
FedEx Corp. (FDX) carries a CleaRank rating of Hold and a model score of 58/100.
The biggest contributor is valuation, where the P/E of 15.82 sits 53.5% below the sector median, a discount to peers, and the P/S of 0.73 is 81.8% below the sector median. The trend is the largest drag: the price is 2.77% below its 200-day average and 5.12% below its 50-day average. Those averages stand at $309.38 for the 50-day and $301.91 for the 200-day. The price has nonetheless climbed 53.77% over the past year.
Only on CleaRank
Figures we compute ourselves from FDX's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
2/4Price above its 50-day average ›
The price of $293.55 is 5.1% below the 50-day simple moving average of $309.38.Price above its 200-day average ›
The price is 2.8% below the 200-day simple moving average of $301.91.50-day average above the 200-day ›
The 50-day average ($309.38) is 2.5% above the 200-day average ($301.91), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 67% of its 52-week range, between $188.98 and $345.37.
FDX share price
Pick a period: each tab shows how far FDX has moved over it, to the last close.
Today's trading
Where FDX sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
5/5P/E below the sector median ›
The trailing P/E of 15.82 is 53.5% below the Industrials median of 34.0.P/S below the sector median ›
The price-to-sales ratio of 0.73 is 81.7% below the sector median of 4.0.Profitable over the last 12 months ›
Net income over the last 12 months was $4.4B on revenue of $94.7B, a net margin of 4.7%.Beat estimates in most recent reports ›
FDX beat the EPS estimate in 5 of its last 7 reports.Pays a dividend ›
The trailing dividend yield is 1.63%, or $4.78 a share a year.
Key statistics
The headline figures for FDX.
As of October 17, 2026, FDX trades at $293.55, with a market value of $69.47B, a P/E ratio of 15.82 and a dividend yield of 1.63%.
What the numbers say
CleaRank Financial AI's reading of FDX's valuation, growth and risks.
FDX trades on a trailing P/E of 15.82, against a Industrials median of 34.0. That places it 53.5% below the sector median, a level the peer comparison on this page labels a discount to peers. Its price-to-sales ratio of 0.73 is 81.8% below the sector median of 4.0. The company carries a market capitalisation of $69.5B, and its trailing earnings stand at $18.55 a share.
Growth outpaces the sector: revenue grew 12.50% in the latest year, against a sector median of 11.7%. FDX keeps a net margin of 4.68% and an operating margin of 11.13%. It generates a return on equity of 14.85%, below the sector median of 17.8%. Rounding out the fundamentals, FDX reports debt-to-equity of 1.36 and a trailing dividend yield of 1.63% ($4.78 a share a year).
In the most recent available report in our data, dated June 23, 2026, FDX beat the estimate by 6.59%. EPS came in at $6.31, compared with the $5.92 analysts had expected. Even so, the share price dropped 0.13% in the next session.
Over its last 7 reports, FDX topped the estimate 5 times; even so, 3 of those 5 beats were followed by a lower share price the next session. Looking ahead, analysts expect EPS of $19.50 this fiscal year (a decline of 3.6%) and $22.18 the year after (growth of 13.7%).
FDX's daily returns have a 30-day standard deviation of 1.39%. While the price stays under its moving averages, the trend is a headwind for holders. The stock is 15.00% below its 52-week high of $345.37. Over the last 18 months insiders sold $23.3M worth of shares and made no open-market purchases. Such sales are often planned in advance, so they carry less weight than buying would.
FDX against the Industrials sector
How FDX compares with the median Industrials stock CleaRank tracks.
Price to earnings vs sector: FDX trades at a notable discount to sector peers (-53%), which may indicate undervaluation or specific company headwinds.
Return vs XLI: Since May 6, 2025, FDX has gained 70.7% against a gain of 25.7% for XLI.
Performance against XLI
FDX and the Industrials sector fund over the same days.
Revenue and earnings
How much FDX sells, and how much of it becomes profit.
Revenue growth: Revenue grew 7.7% in FY2026 to $94.7B, from $87.9B a year earlier.
Profit margin: The net margin was 4.7% in FY2026, up from 4.7% the year before.
Profitable: FDX earned $4.4B in FY2026.
Earnings reality check
Did FDX beat what analysts expected, and how did the stock react?
Earnings record: FDX beat the analyst estimate in 5 of the last 7 quarters.
Market reaction: The stock fell in the first session after 3 of those 5 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jun 23, 2026after close | $5.92 | $6.31 | +6.59% | -0.13% | -1.30% |
| Mar 19, 2026after close | $4.18 | $5.25 | +25.60% | +0.77% | -1.84% |
| Sep 18, 2025after close | $3.61 | $3.83 | +6.09% | +2.32% | +4.38% |
| Jun 24, 2025after close | $5.80 | $6.07 | +4.66% | -3.27% | +2.10% |
| Mar 20, 2025after close | $4.63 | $4.51 | -2.59% | -6.45% | -0.93% |
| Dec 19, 2024after close | $3.97 | $4.05 | +2.02% | -0.05% | +1.62% |
| Sep 19, 2024after close | $4.77 | $3.60 | -24.53% | -15.23% | -11.34% |
Reports after June 23, 2026 are not yet in our data.
As of October 17, 2026, FDX has beaten the analyst EPS estimate in 5 of its last 7 reported quarters and fell in the first trading session after 3 of those beats; its most recent report in our data, on June 23, 2026, came in 6.59% above the estimate and the stock moved -0.13% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 45.7, in neutral territory.RSI above 50 ›
An RSI of 45.7 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of FDX
The score, the reasoning behind it, and what could move the price next.
FedEx Corp. (FDX) is trending down. The stock, at $293.55, sits 5.12% below its 50-day average of $309.38 and 2.77% below its 200-day average of $301.91. Over the past year, the price is 55.33% above the 52-week low of $188.98, yet 15.00% below the high of $345.37.
A recent pullback sits inside a stronger longer record: the price fell 2.71% over the past month, fell 6.21% over the past three months and rose 53.77% over the past year. The 14-day RSI of 45.7 is in the neutral zone, and the MACD line is negative.
Earnings beat ›
The June 23, 2026 report beat the EPS estimate by 6.59%, and the share price fell 0.13% in the first session after it.
Source: Earnings report, June 23, 2026
Rating reaffirmed ›
Citigroup kept its Buy rating on October 7, 2026.
Source: Analyst action, Citigroup, October 7, 2026
- Keep an eye on the two closest levels: the 20-day EMA at $294.17, which sits above the price, and the 52-week low at $188.98, which sits below it.
- The 14-day RSI reads 45.7, in the neutral zone, with the MACD line negative; readings above 70 or below 30 mark stretched momentum.
- Following the June 23, 2026 report, the share price fell 0.13% in the first session. Over the last 7 reports, FDX has beaten estimates in 5 of them.
The trend is down because FDX sits beneath both its 50-day ($309.38) and 200-day ($301.91) averages. Reclaiming the 200-day would be the first hint of recovery. Directly overhead, the 20-day EMA at $294.17 is the nearest level the price must clear.
The next level below the price is the 52-week low, at $188.98.
Technical indicators
Momentum and trend for FDX, from its daily closes.
As of October 17, 2026, with FDX at $293.55, its 14-day RSI is 45.7 (neutral territory), its 50-day simple moving average is $309.38 and its 200-day is $301.91.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What FDX moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, FDX's 1-year correlation of daily returns is +0.49 with S&P 500 (SPY), +0.38 with Nasdaq 100 (QQQ), +0.03 with Bitcoin (BTC) and +0.07 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
20 of 28 analysts rate it a buy or strong buy, 7 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $352.50 is 20.1% above the price.More buy ratings than three months ago ›
20 of 28 rate it a buy now, against 20 of 28 three months ago.
FDX Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 7, 2026 | Citigroup | Maintains | Buy |
| Oct 7, 2026 | Truist Securities | Maintains | Buy |
| Oct 5, 2026 | JP Morgan | Maintains | Overweight |
| Sep 28, 2026 | Evercore ISI Group | Maintains | In-Line |
| Sep 9, 2026 | Evercore ISI Group | Maintains | In-Line |
| Sep 8, 2026 | JP Morgan | Maintains | Overweight |
As of October 17, 2026, 28 Wall Street analysts cover FDX: 20 rate it a buy or strong buy, 7 a hold and 1 a sell or strong sell. Their 12-month price targets range from $160.00 to $479.00, with a median of $352.50, 20.1% above the price of $293.55.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
FDX trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from FDX's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much FDX tends to move, against the market and on its own.
The long record
FDX's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 1.39% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 63.0%, from January 2018 to March 2020, regained by October 2020.Most 1-year holds ended higher ›
57% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $25,929, against $42,055 in the S&P 500 (SPY).
FDX Drawdowns & Recovery
As of October 17, 2026, FDX's worst peak-to-trough fall over the last 10 years with dividends reinvested was -63.0% (January 2018 to March 2020); it regained that peak by October 2020, 7 months after the low, and 57% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into FDX in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: FDX trailed the S&P 500 over this period: $25,929 against $42,055.
A $10,000 investment in FDX in October 2016 would be worth about $25,929 today with dividends reinvested, compared with about $42,055 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to FDX, and which have not.
Strongest month, November: an average of +6.87%, up in 9 of 10 years.
Weakest month, September: an average of -4.80%, up in 4 of 10 years.
This month, October: has averaged +1.55%, up in 7 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, FDX's strongest calendar month has been November (average +6.87%, up in 9 of 10 years) and its weakest September (average -4.80%, up in 4 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in FDX, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in FDX today could grow to about $19,576 by 2036 in the base case, with a 90th-percentile outcome near $75,623 and a 10th-percentile outcome around $5,068. The simulation models price only; at today's 1.63% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
FDX Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $384 for FDX by 2030 in the base case, from $294 today (1.3x over 4 years). The 10th-percentile path ends near $163. These are outcomes of a Monte Carlo simulation run on FDX's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $205 | $314 | $481 | |
| 2028 | $183 | $336 | $614 | |
| 2029 | $171 | $359 | $753 | |
| 2030 | $163 | $384 | $903 | |
| 2031 | $158 | $411 | $1,068 |
Method: a lognormal simulation of FDX's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
FDX insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought FDX shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 17, 2026, FDX insiders reported 10 open-market sales worth $23.3M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Aug 28, 2026 | Marvin R Ellison
Director
|
Option | 5.0K | $695.0K |
| Aug 17, 2026 | Vishal Talwar
Officer
|
Grant | 1.5K | - |
| Jul 2, 2026 | Gina F Adams
General Counsel
|
Grant | 4.7K | - |
| Jul 2, 2026 | Vishal Talwar
Officer
|
Grant | 4.7K | - |
| Jun 30, 2026 | Paul S Walsh
Director
|
Sell | 5.0K | $1.6M |
| Jun 30, 2026 | Paul S Walsh
Director
|
Option | 5.0K | $695.0K |
| Jun 25, 2026 | Gina F Adams
General Counsel
|
Grant | 4.7K | - |
| Jun 25, 2026 | Tracy B Brightman
Officer
|
Grant | 4.7K | - |
| Jun 25, 2026 | Brie Carere
Officer
|
Grant | 4.7K | - |
| Jun 25, 2026 | Mark A. Edmunds
Director
|
Grant | 187 | - |
| Jun 25, 2026 | Robert Brad Martin
Officer and Director
|
Grant | 8.7K | - |
| Jun 25, 2026 | Kawal Preet
Officer
|
Grant | 4.7K | - |
| Jun 25, 2026 | Scott L. Ray
Officer
|
Grant | 4.7K | - |
| Jun 25, 2026 | Claude F. Russ
Chief Financial Officer
|
Grant | 1.6K | - |
| Jun 25, 2026 | Richard W. Smith
Officer and Director
|
Grant | 4.7K | - |
| Jun 25, 2026 | Rajesh Subramaniam
Chief Executive Officer
|
Grant | 14.6K | - |
| Jun 25, 2026 | Vishal Talwar
Officer
|
Grant | 4.7K | - |
| May 5, 2026 | Susan Patricia Griffith
Director
|
Option | 4.1K | $1.0M |
| Apr 27, 2026 | Stephen E Gorman
Director
|
Option | 4.7K | $693.1K |
| Apr 20, 2026 | Rajesh Subramaniam
Chief Executive Officer
|
Option | 21.3K | $4.9M |
| Apr 15, 2026 | Tracy B Brightman
Officer
|
Sell | 17.0K | $6.2M |
| Apr 15, 2026 | Susan C Schwab
Director
|
Sell | 5.8K | $2.1M |
| Apr 15, 2026 | Tracy B Brightman
Officer
|
Option | 11.9K | $3.0M |
| Apr 15, 2026 | Susan C Schwab
Director
|
Option | 5.8K | $1.3M |
| Apr 14, 2026 | Gina F Adams
General Counsel
|
Sell | 20.5K | $7.5M |
| Apr 14, 2026 | Kawal Preet
Officer
|
Sell | 4.9K | $1.8M |
| Apr 14, 2026 | Brie Carere
Officer
|
Sell | 2.7K | $999.1K |
| Apr 14, 2026 | Gina F Adams
General Counsel
|
Option | 20.5K | $3.1M |
| Apr 14, 2026 | Guy M Erwin II
Officer
|
Option | 5.3K | $1.3M |
| Apr 14, 2026 | Robert Brad Martin
Officer and Director
|
Option | 15.1K | $2.8M |
| Apr 14, 2026 | Kawal Preet
Officer
|
Option | 4.9K | $1.0M |
| Apr 14, 2026 | Richard W. Smith
Officer and Director
|
Option | 3.8K | $619.5K |
| Apr 14, 2026 | Richard W. Smith
Officer and Director
|
Grant | 600 | - |
| Mar 23, 2026 | Robert Brad Martin
Officer and Director
|
Grant | 4.2K | - |
| Feb 18, 2026 | Rajesh Subramaniam
Chief Executive Officer
|
Option | 13.2K | $2.2M |
| Sep 29, 2025 | Silvia Davila
Director
|
Grant | 1.1K | $69.9K |
| Sep 29, 2025 | Marvin R Ellison
Director
|
Grant | 1.1K | $69.9K |
| Sep 29, 2025 | Stephen E Gorman
Director
|
Grant | 823 | - |
| Sep 29, 2025 | Susan Patricia Griffith
Director
|
Grant | 1.4K | $140.0K |
| Sep 29, 2025 | Amy Beth Lane
Director
|
Grant | 823 | - |
| Sep 29, 2025 | Robert Brad Martin
Officer and Director
|
Grant | 6.4K | - |
| Sep 29, 2025 | Nancy A Norton
Director
|
Grant | 823 | - |
| Sep 29, 2025 | Frederick Perpall
Director
|
Grant | 823 | - |
| Sep 29, 2025 | Joshua Cooper Ramo
Director
|
Grant | 1.4K | $140.0K |
| Sep 29, 2025 | Susan C Schwab
Director
|
Grant | 1.1K | $69.9K |
| Sep 29, 2025 | Paul S Walsh
Director
|
Grant | 823 | - |
| Sep 22, 2025 | Vishal Talwar
Officer
|
Grant | 9.3K | - |
| Jul 23, 2025 | Joshua Cooper Ramo
Director
|
Sell | 3.6K | $838.4K |
| Jul 23, 2025 | Joshua Cooper Ramo
Director
|
Option | 3.6K | $513.0K |
| Jul 9, 2025 | Marvin R Ellison
Director
|
Sell | 3.6K | $855.4K |
| Jul 9, 2025 | Marvin R Ellison
Director
|
Option | 3.6K | $513.0K |
| Jul 8, 2025 | Paul S Walsh
Director
|
Sell | 3.6K | $860.2K |
| Jul 8, 2025 | Paul S Walsh
Director
|
Option | 3.6K | $513.0K |
| Jul 7, 2025 | Robert Brad Martin
Director
|
Sell | 2.1K | $513.2K |
| Jul 7, 2025 | Robert Brad Martin
Director
|
Option | 3.6K | $513.0K |
| Jun 26, 2025 | Gina F Adams
General Counsel
|
Grant | 6.3K | - |
| Jun 26, 2025 | Tracy B Brightman
Officer
|
Grant | 6.3K | - |
| Jun 26, 2025 | Brie Carere
Officer
|
Grant | 6.3K | - |
| Jun 26, 2025 | John W Dietrich
Chief Financial Officer
|
Grant | 6.6K | - |
| Jun 26, 2025 | Guy M Erwin II
Officer
|
Grant | 1.2K | - |
| Jun 26, 2025 | Sriram Krishnasamy
Officer
|
Grant | 6.3K | - |
| Jun 26, 2025 | John Alan Smith
Officer
|
Grant | 6.3K | - |
| Jun 26, 2025 | Richard W. Smith
Officer
|
Grant | 6.3K | - |
| Jun 26, 2025 | Rajesh Subramaniam
Chief Executive Officer
|
Grant | 17.7K | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.